Fenmetozole (DH-524) is a drug which was patented as an antidepressant but was later studied as an antagonist of the effects of ethanol though results were poor and it even increased its effects in some cases. It acts as an α2-adrenergic receptor antagonist similarly to other imidazoles like idazoxan. It was never marketed.
This page contains content from the copyrighted Wikipedia article "Fenmetozole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
